level, in such companies as Hoechst (now Aventis), BASF, Bayer, the NY Blood Center/Melville Biologics and VI Technologies.Dr. Page has extensive FDA audit experience (annual audits, licensing inspections & product meetings) and 483/warning letter/consent decree response and remediation program development.